Schlenk J, Seidl S, Braunschweiger G, Betz P, Lederer T
Institute of Legal Medicine, University of Erlangen-Nürnberg, Universitätsstrasse 22, 91054 Erlangen, Germany.
Int J Legal Med. 2004 Feb;118(1):55-61. doi: 10.1007/s00414-003-0420-5. Epub 2004 Jan 14.
In this study the development of a 13-locus multiplex-PCR system fitting the updated demands for paternity testing in Germany is described. For this purpose an existing multiplex PCR system that allows the simultaneous amplification of eight different STR loci together with the sex-specific locus amelogenin ( genRESMPX-2, Serac, Germany) was extended. Whereas some of the primers were taken from the underlying multiplex system, suitable primer sequences were chosen for the STR loci D19S433, TPOX, TH01, D16S539, D5S818, D2S1338 and FGA. Primers of loci resulting in potentially overlapping fragment sizes were labelled with the fluorescent dyes 6-FAM, JOE and NED. Reaction conditions, such as annealing temperature, concentrations of primers and polymerase or buffer conditions were optimised to obtain a robust amplification and reproducible genotype analysis for various sample sources. Full DNA profiles from single source samples were reliably typed from template DNA amounts of as low as 120 pg, suggesting a potential use of this system also in forensic casework analysis. With a mean exclusion chance (MEC) of 99.9989% and a power of discrimination (P(D)) of about 1x10(14) (Caucasians), the new multiplex PCR system provides a significant and sensitive system for forensic DNA analysis. On the basis of these studies, a commercial kit system is now provided by Serac (Bad Homburg, Germany, genRESMPX-3).
本研究描述了一种符合德国亲子鉴定最新要求的13位点多重聚合酶链反应(PCR)系统的开发。为此,对现有的多重PCR系统进行了扩展,该系统能够同时扩增八个不同的短串联重复序列(STR)位点以及性别特异性位点牙釉蛋白(genRESMPX - 2,Serac公司,德国)。虽然部分引物取自基础多重系统,但针对STR位点D19S433、TPOX、TH01、D16S539、D5S818、D2S1338和FGA选择了合适的引物序列。对可能产生重叠片段大小的位点的引物用荧光染料6 - FAM、JOE和NED进行标记。对退火温度、引物和聚合酶浓度或缓冲液条件等反应条件进行了优化,以实现对各种样本来源的稳健扩增和可重复的基因型分析。从低至120 pg的模板DNA量中可靠地分型了单一样本来源的完整DNA图谱,这表明该系统在法医案件分析中也具有潜在用途。新的多重PCR系统平均排除几率(MEC)为99.9989%,鉴别能力(P(D))约为1×10(14)(高加索人),为法医DNA分析提供了一个显著且灵敏的系统。基于这些研究,Serac公司(德国巴特洪堡,genRESMPX - 3)现提供一种商业试剂盒系统。